{
    "nctId": "NCT02080390",
    "briefTitle": "Strain Imaging in Breast Cancer Patients Receiving Trastuzumab",
    "officialTitle": "Strain Imaging in Breast Cancer Patients Receiving Trastuzumab",
    "overallStatus": "COMPLETED",
    "conditions": "Her 2 Positive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "Longitudinal Strain",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age greater than 18 years\n* Her 2 positive breast cancer.\n* Patients who are currently receiving Trastuzumab (Herceptin).\n* Patients who received Trastuzumab (Herceptin) after the formation of the UFHealth Medical Plaza pharmacy database was initiated.\n\nExclusion Criteria:\n\n* Age less than 18 years\n* Patients who have not received Trastuzumab (Herceptin).\n* Patients who received Trastuzumab prior to the formation of the UFHealth Medical Plaza pharmacy database.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}